ホーム > 市場調査レポート > 医薬品

再生医療細胞治療

市場調査レポート

商品コード

1510610

北米のバイオ生産市場：2030年予測- 製品別、用途別、装置別、エンドユーザー別、国別

North America Bioproduction Market Forecast to 2030 - Regional Analysis - by Product, Application, Equipment, and End User

出版日: 2024年05月07日
発行: The Insight Partners
ページ情報: 英文 95 Pages
納期: 即納可能

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

北米のバイオ生産市場は、2022年に109億4,748万米ドルと評価され、2030年には313億7,365万米ドルに達すると予測され、2022年から2030年までのCAGRは14.1%と推定されます。

再生医療の普及が北米のバイオ生産市場を後押し

再生療法は、細胞、組織、臓器の再生に役立ち、その機能を回復させる。毎年、多くの再生医療がヒト臨床試験のために食品医薬品局（FDA）に申請されています。Alliance for Regenerative Medicineによると、2019年（第3四半期）には、再生医療を活用した1,052件の臨床試験が世界で進行中であり、2019年には218件の細胞治療試験が進行中（第I相試験41件、第II相試験147件、第III相試験30件）でした。慢性疾患に対する効果的な解決策を提供するため、再生医療の急速な進歩が進んでいます。細胞療法は、再生医療領域で最も急成長している分野の1つです。ノバルティスのKymriahは、B細胞性急性白血病の治療に提供された最初の細胞治療ソリューションです。さらに、再生医療プロバイダーであるレプリセル社は、幅広い再生医療製品をパイプラインに持っており、3つの製品-RCH-01、RCS-01、RCT-01が開発段階にあります。さらに、Sernova社は再生医療技術の開発に取り組んでおり、糖尿病、血友病A、甲状腺機能亢進症などの症状に対する製品の膨大なパイプラインを持っています。このように、再生医療の採用拡大がバイオ生産市場を牽引しています。

北米のバイオ生産市場概要

北米のバイオ生産市場は、米国、カナダ、メキシコに細分化されます。メキシコでは、幹細胞治療を目的としたメディカルツーリズムの増加により、細胞治療の需要が非常に注目されています。北米のバイオ生産市場は、糖尿病や不妊症の罹患率の増加、バイオシミラーの製品開発の高まりにより、2022年に最大の市場シェアを占めました。

遺伝性疾患や細胞性疾患の増加により、細胞療法の需要が高まっています。2020年のPhRMAの細胞・遺伝子治療パイプラインに関する報告書によると、米国ではがんから遺伝性疾患、神経疾患まで様々な疾患や病態を対象とした400の細胞・遺伝子治療が開発中であることが明らかになった。2020年2月現在、米国ではがん、眼疾患、希少遺伝性疾患の治療を目的とした9つの細胞・遺伝子治療薬が承認されています。また、米国では細胞療法を革新する新興企業が増えています。

北米のバイオ生産市場の収益と2030年までの予測（金額）

北米のバイオ生産市場のセグメンテーション

北米のバイオ生産市場は、製品、用途、装置、エンドユーザー、地域に分類されます。

製品別に見ると、北米のバイオ生産市場は、生物製剤とバイオシミラー、ワクチン、細胞・遺伝子治療薬、核酸治療薬、その他に区分されます。2022年の北米のバイオ生産市場シェアは、生物製剤とバイオシミラーセグメントが最大でした。

用途別では、北米のバイオ生産市場は、関節リウマチ、血液疾患、がん、糖尿病、心血管疾患、その他に区分されます。2022年の北米のバイオ生産市場シェアは、がん分野が最大でした。

装置別では、北米のバイオ生産市場はアップストリーム装置、ダウンストリーム装置、バイオリアクター、消耗品・アクセサリーに分けられます。消耗品・付属品セグメントは、2022年に北米のバイオ生産市場で最大のシェアを占めました。

エンドユーザー別では、北米のバイオ生産市場はバイオ医薬品企業、受託製造機関、その他に分類されます。2022年の北米のバイオ生産市場シェアは、バイオ製薬会社セグメントが最大でした。

国別では、北米のバイオ生産市場は米国、カナダ、メキシコに区分されます。2022年の北米のバイオ生産市場シェアは米国が独占しました。

Bio-Rad Laboratories Inc、Danaher Corp、F. Hoffmann-La Roche Ltd、Lonza Group AG、Merck KGaA、Sartorius AG、Thermo Fisher Scientific Inc.は、北米のバイオ生産市場で事業を展開している大手企業の一部です。

List Of Tables

Table 1. North America Bioproduction Market Segmentation
Table 2. North America Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 3. US Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 4. US Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 5. US Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 6. US Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 7. US Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 8. Canada Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 9. Canada Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 10. Canada Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 11. Canada Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 12. Canada Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 13. Mexico Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 14. Mexico Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 15. Mexico Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 16. Mexico Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 17. Mexico Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 18. Recent Inorganic Growth Strategies in the Bioproduction Market
Table 19. Recent Organic Growth Strategies in the Bioproduction Market
Table 20. Glossary of Terms, Bioproduction Market

List Of Figures

Figure 1. North America Bioproduction Market Segmentation, By Country
Figure 2. North America Bioproduction Market: Key Industry Dynamics
Figure 3. North America Bioproduction Market: Impact Analysis of Drivers and Restraints
Figure 4. North America Bioproduction Market Revenue (US$ Mn), 2020 - 2030
Figure 5. North America Bioproduction Market Revenue Share, by Product 2022 & 2030 (%)
Figure 6. Biologics and Biosimilars: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Vaccines: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Cell and Gene Therapies: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Nucleic Acid Therapeutics: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Others: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. North America Bioproduction Market Revenue Share, by Application 2022 & 2030 (%)
Figure 12. Cancer: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Cardiovascular Diseases: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Rheumatoid Arthritis: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Hematological Disorders: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Diabetes: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Others: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. North America Bioproduction Market Revenue Share, by Equipment 2022 & 2030 (%)
Figure 19. Consumables and Accessories: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Downstream Equipment: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Bioreactors: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Upstream Equipment: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. North America Bioproduction Market Revenue Share, by End User 2022 & 2030 (%)
Figure 24. Biopharmaceutical Companies: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Contract Manufacturing Organizations: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. Others: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. North America: Bioproduction Market, by Key Country - Revenue (2022) (US$ Million)
Figure 28. North America: Bioproduction Market, by Country, 2022 & 2030 (%)
Figure 29. US: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 30. Canada: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 31. Mexico: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 32. Growth Strategies in the Bioproduction Market

Product Code: BMIRE00030058

The North America bioproduction market was valued at US$ 10,947.48 million in 2022 and is expected to reach US$ 31,373.65 million by 2030; it is estimated to register a CAGR of 14.1% from 2022 to 2030.

Rising Adoption of Regenerative Medicines Fuels North America Bioproduction Market

Regenerative therapies help in the regeneration of cells, tissues, and organs to restore their functions. A number of regenerative medicine applications for human clinical trials are submitted to the Food and Drug Administration (FDA) each year. As per the Alliance for Regenerative Medicine, in 2019 (Q3), 1,052 clinical trials utilizing regenerative medicine were underway globally; 218 cellular therapy trials were underway (41 Phase I, 147 Phase II, 30 Phase III) in 2019. Rapid advancements are being made in regenerative medicines to provide effective solutions for chronic conditions. Cell therapy is one of the fastest-growing segments of the regenerative medicine domain. Novartis' Kymriah was the first cell therapy solution offered to treat B-cell acute leukemia. Moreover, RepliCel, a regenerative medicine provider, has a wide range of regenerative medicine products in the pipeline, with three products-RCH-01, RCS-01, and RCT-01-in the development phase. Further, Sernova is engaged in the development of regenerative medicine technologies and has a huge pipeline of products for conditions such as diabetes, hemophilia A, and hyperthyroidism. Thus, the rising adoption of regenerative medicines is driving the bioproduction market.

North America Bioproduction Market Overview

The North America bioproduction market is subsegmented into the US, Canada, and Mexico. In Mexico, the demand for cell therapy is quite noteworthy owing to growing medical tourism for stem cell therapy. The bioproduction market in North America accounted for the largest market share in 2022 due to increasing incidence of diabetes and infertility, as well as rising product developments in biosimilars.

Growing incidences of genetic and cellular disorders are leading to increasing demand for cell therapies. A 2020 PhRMA report on the cell and gene therapy pipeline revealed that there are 400 cell and gene therapies in development to target a variety of diseases and conditions from cancer to genetic disorders to neurologic conditions in the US. As of February 2020, nine cell or gene therapy products were approved in the US to treat cancer, eye diseases and rare hereditary diseases. Also, an increasing number of start-ups are innovating cell therapies in the country.

North America Bioproduction Market Revenue and Forecast to 2030 (US$ Million)

North America Bioproduction Market Segmentation

The North America bioproduction market is categorized into product, application, equipment, end user, and country.

Based on product, the North America bioproduction market is segmented into biologics and biosimilars, vaccines, cell and gene therapies, nucleic acid therapeutics, and others. The biologics and biosimilars segment held the largest North America bioproduction market share in 2022.

In terms of application, the North America bioproduction market is segmented into rheumatoid arthritis, hematological disorders, cancer, diabetes, cardiovascular diseases, and others. The cancer segment held the largest North America bioproduction market share in 2022.

By equipment, the North America bioproduction market is divided into upstream equipment, downstream equipment, bioreactors, and consumables and accessories. The consumables and accessories segment held the largest North America bioproduction market share in 2022.

In terms of end user, the North America bioproduction market is categorized into biopharmaceutical companies, contract manufacturing organizations, and others. The biopharmaceutical companies segment held the largest North America bioproduction market share in 2022.

By country, the North America bioproduction market is segmented into the US, Canada, and Mexico. The US dominated the North America bioproduction market share in 2022.

Bio-Rad Laboratories Inc, Danaher Corp, F. Hoffmann-La Roche Ltd, Lonza Group AG, Merck KGaA, Sartorius AG, and Thermo Fisher Scientific Inc. are some of the leading companies operating in the North America bioproduction market.

Table of Content

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. North America Bioproduction Market - Key Industry Dynamics

4.1 Market Drivers
- 4.1.1 Rising Adoption of Regenerative Medicines
- 4.1.2 Increasing Prevalence of Chronic Diseases
4.2 Market Restraints
- 4.2.1 High Cost of Cell Therapy and Biosimilar Manufacturing
4.3 Market Opportunities
- 4.3.1 Patent Expiry of Blockbuster Biologics
4.4 Future Trends
- 4.4.1 Shift Toward Automated Cell Therapy Manufacturing
4.5 Impact Analysis

5. Bioproduction Market - North America Market Analysis

5.1 North America Bioproduction Market Revenue (US$ Mn), 2020 - 2030

6. North America Bioproduction Market - Revenue and Forecast to 2030 - by Product

6.1 Overview
6.2 North America Bioproduction Market Revenue Share, by Product 2022 & 2030 (%)
6.3 Biologics and Biosimilars
- 6.3.1 Overview
- 6.3.2 Biologics and Biosimilars: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Vaccines
- 6.4.1 Overview
- 6.4.2 Vaccines: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Cell and Gene Therapies
- 6.5.1 Overview
- 6.5.2 Cell and Gene Therapies: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.6 Nucleic Acid Therapeutics
- 6.6.1 Overview
- 6.6.2 Nucleic Acid Therapeutics: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.7 Others
- 6.7.1 Overview
- 6.7.2 Others: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

7. North America Bioproduction Market - Revenue and Forecast to 2030 - by Application

7.1 Overview
7.2 North America Bioproduction Market Revenue Share, by Application 2022 & 2030 (%)
7.3 Cancer
- 7.3.1 Overview
- 7.3.2 Cancer: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Cardiovascular Diseases
- 7.4.1 Overview
- 7.4.2 Cardiovascular Diseases: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Rheumatoid Arthritis
- 7.5.1 Overview
- 7.5.2 Rheumatoid Arthritis: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Hematological Disorders
- 7.6.1 Overview
- 7.6.2 Hematological Disorders: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Diabetes
- 7.7.1 Overview
- 7.7.2 Diabetes: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.8 Others
- 7.8.1 Overview
- 7.8.2 Others: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Bioproduction Market - Revenue and Forecast to 2030 - by Equipment

8.1 Overview
8.2 North America Bioproduction Market Revenue Share, by Equipment 2022 & 2030 (%)
8.3 Consumables and Accessories
- 8.3.1 Overview
- 8.3.2 Consumables and Accessories: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Downstream Equipment
- 8.4.1 Overview
- 8.4.2 Downstream Equipment: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Bioreactors
- 8.5.1 Overview
- 8.5.2 Bioreactors: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
  - 8.5.2.1 North America: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
8.6 Upstream Equipment
- 8.6.1 Overview
- 8.6.2 Upstream Equipment: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Bioproduction Market - Revenue and Forecast to 2030 - by End User

9.1 Overview
9.2 North America Bioproduction Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Biopharmaceutical Companies
- 9.3.1 Overview
- 9.3.2 Biopharmaceutical Companies: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Contract Manufacturing Organizations
- 9.4.1 Overview
- 9.4.2 Contract Manufacturing Organizations: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Others
- 9.5.1 Overview
- 9.5.2 Others: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

10. North America Bioproduction Market - Revenue and Forecast to 2030 - Country Analysis

10.1 North America: Bioproduction Market
- 10.1.1 US: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
  - 10.1.1.1 Overview
  - 10.1.1.2 US: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
  - 10.1.1.3 US: Bioproduction Market, by Product, 2020-2030 (US$ Million)
  - 10.1.1.4 US: Bioproduction Market, by Application, 2020-2030 (US$ Million)
  - 10.1.1.5 US: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
    - 10.1.1.5.1 US: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
  - 10.1.1.6 US: Bioproduction Market, by End User, 2020-2030 (US$ Million)
  - 10.1.1.2 Canada: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.2.1 Overview
    - 10.1.1.2.2 Canada: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.2.3 Canada: Bioproduction Market, by Product, 2020-2030 (US$ Million)
    - 10.1.1.2.4 Canada: Bioproduction Market, by Application, 2020-2030 (US$ Million)
    - 10.1.1.2.5 Canada: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
    - 10.1.1.2.5.1 Canada: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
    - 10.1.1.2.6 Canada: Bioproduction Market, by End User, 2020-2030 (US$ Million)
  - 10.1.1.3 Mexico: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.3.1 Overview
    - 10.1.1.3.2 Mexico: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.3.3 Mexico: Bioproduction Market, by Product, 2020-2030 (US$ Million)
    - 10.1.1.3.4 Mexico: Bioproduction Market, by Application, 2020-2030 (US$ Million)
    - 10.1.1.3.5 Mexico: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
    - 10.1.1.3.5.1 Mexico: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
    - 10.1.1.3.6 Mexico: Bioproduction Market, by End User, 2020-2030 (US$ Million)

11. Bioproduction Market-Industry Landscape

11.1 Overview
11.2 Growth Strategies in the Bioproduction Market
11.3 Inorganic Growth Strategies
- 11.3.1 Overview
11.4 Organic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 Lonza Group AG
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Danaher Corp
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Sartorius AG
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Thermo Fisher Scientific Inc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Merck KGaA
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 F. Hoffmann-La Roche Ltd
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Bio-Rad Laboratories Inc
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments

13. Appendix

13.1 About Us
13.2 Glossary of Terms

北米のバイオ生産市場：2030年予測- 製品別、用途別、装置別、エンドユーザー別、国別

North America Bioproduction Market Forecast to 2030 - Regional Analysis - by Product, Application, Equipment, and End User

全表示

目次

第1章イントロダクション

第2章エグゼクティブサマリー

第3章調査手法

第4章北米のバイオ生産市場- 主要産業力学

第5章バイオ生産市場：北米市場分析

第6章北米のバイオ生産市場：製品別収益と2030年までの予測

第7章北米バイオ医薬品市場：用途別収益と2030年までの予測

第8章北米のバイオ生産市場：装置別収益と2030年までの予測

第9章北米のバイオ生産市場：エンドユーザー別収益と2030年までの予測

第10章北米のバイオ生産市場の収益と2030年までの予測：国別分析

第11章バイオ生産市場-業界情勢

第12章企業プロファイル

第13章付録

List Of Tables

List Of Figures

Table Of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. North America Bioproduction Market - Key Industry Dynamics

5. Bioproduction Market - North America Market Analysis

6. North America Bioproduction Market - Revenue and Forecast to 2030 - by Product

7. North America Bioproduction Market - Revenue and Forecast to 2030 - by Application

8. North America Bioproduction Market - Revenue and Forecast to 2030 - by Equipment

9. North America Bioproduction Market - Revenue and Forecast to 2030 - by End User

10. North America Bioproduction Market - Revenue and Forecast to 2030 - Country Analysis

11. Bioproduction Market-Industry Landscape

12. Company Profiles

13. Appendix

北米のバイオ生産市場：2030年予測- 製品別、用途別、装置別、エンドユーザー別、国別

North America Bioproduction Market Forecast to 2030 - Regional Analysis - by Product, Application, Equipment, and End User

全表示

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 北米のバイオ生産市場- 主要産業力学

第5章 バイオ生産市場：北米市場分析

第6章 北米のバイオ生産市場：製品別収益と2030年までの予測

第7章 北米バイオ医薬品市場：用途別収益と2030年までの予測

第8章 北米のバイオ生産市場：装置別収益と2030年までの予測

第9章 北米のバイオ生産市場：エンドユーザー別収益と2030年までの予測

第10章 北米のバイオ生産市場の収益と2030年までの予測：国別分析

第11章 バイオ生産市場-業界情勢

第12章 企業プロファイル

第13章 付録

List Of Tables

List Of Figures

Table Of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. North America Bioproduction Market - Key Industry Dynamics

5. Bioproduction Market - North America Market Analysis

6. North America Bioproduction Market - Revenue and Forecast to 2030 - by Product

7. North America Bioproduction Market - Revenue and Forecast to 2030 - by Application

8. North America Bioproduction Market - Revenue and Forecast to 2030 - by Equipment

9. North America Bioproduction Market - Revenue and Forecast to 2030 - by End User

10. North America Bioproduction Market - Revenue and Forecast to 2030 - Country Analysis

11. Bioproduction Market-Industry Landscape

12. Company Profiles

13. Appendix

第1章イントロダクション

第2章エグゼクティブサマリー

第3章調査手法

第4章北米のバイオ生産市場- 主要産業力学

第5章バイオ生産市場：北米市場分析

第6章北米のバイオ生産市場：製品別収益と2030年までの予測

第7章北米バイオ医薬品市場：用途別収益と2030年までの予測

第8章北米のバイオ生産市場：装置別収益と2030年までの予測

第9章北米のバイオ生産市場：エンドユーザー別収益と2030年までの予測

第10章北米のバイオ生産市場の収益と2030年までの予測：国別分析

第11章バイオ生産市場-業界情勢

第12章企業プロファイル

第13章付録